News archive

Novartis maintained its position in the 2021 Access to Medicine Index, leading in its approach to product delivery, while performing strongly across all other areas of the Index.

The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.

The Co-Creating Impact Summit happening on December 9th, 2020, will gather experts inside and outside of Novartis to continue our work of improving our impact on the society and the planet.

Novartis Chief Digital Officer, Bertrand Bodson, and Microsoft Corporate Vice President Research & Incubation, Peter Lee, discussed why healthcare’s digital moment is now.

Five virtual power purchase agreements with three developers expected to add more than 275 megawatts of clean power to the electrical grid.

NIBR translational immunologists and academic colleagues observe two distinct molecular patterns of disease progression in lung tissue samples.

Learn how we’re working with partners like the International Agency for the Prevention of Blindness to eliminate preventable blindness.

Commitments to expanded global access for COVID-19 diagnostics, therapeutics, and vaccines.

September 29 is World Heart Day. For the past six decades, Novartis has been working to advance heart health around the world.

Latest oncology resources and news surrounding Novartis data featured at European Society for Medical Oncology (ESMO)